Genetic prediction of impulse control disorders in Parkinson's disease
Abstract Objective To develop a clinico‐genetic predictor of impulse control disorder (ICD) risk in Parkinson's disease (PD). Methods In 5770 individuals from three PD cohorts (the 23andMe, Inc.; the University of Pennsylvania [UPenn]; and the Parkinson's Progression Markers Initiative [PP...
Main Authors: | Daniel Weintraub, Marijan Posavi, Pierre Fontanillas, Thomas F. Tropea, Eugenia Mamikonyan, Eunran Suh, John Q. Trojanowski, Paul Cannon, Vivianna M. Van Deerlin, 23andMe Research Team, Alice S. Chen‐Plotkin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-07-01
|
Series: | Annals of Clinical and Translational Neurology |
Online Access: | https://doi.org/10.1002/acn3.51569 |
Similar Items
-
Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson’s disease
by: Cheryl E. G. Leyns, et al.
Published: (2023-05-01) -
Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.
by: Marijan Posavi, et al.
Published: (2019-10-01) -
Are Parkinson’s Disease Patients the Ideal Preclinical Population for Alzheimer’s Disease Therapeutics?
by: Thomas F. Tropea, et al.
Published: (2021-08-01) -
Further validation of the THINC‐it tool and extension of the normative data set in a study of n = 10.019 typical controls
by: Maria Dalby, et al.
Published: (2022-12-01) -
Analysis of rare Parkinson’s disease variants in millions of people
by: Vanessa Pitz, et al.
Published: (2024-01-01)